Hydrochloric Acid

Hydrochloric Acid

SCHEMBL15914484

CC(=N)N[C@@H](CCCCN)C(=O)O.Cl.Cl

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CA2 known ✓ P00918 1/20 0.42
FOLH1 Q04609 2/20 0.57
SLC6A5 Q9Y345 1/20 0.48
GSR P00390 1/20 0.44
RNPEP Q9H4A4 1/20 0.43
CPB2 Q96IY4 9/20 0.42
SIRT6 Q8N6T7 1/20 0.42
SIRT1 Q96EB6 1/20 0.42
CA1 P00915 1/20 0.42
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
GNPAT O15228 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2166126 1.00 FOLH1 (0.57) FOLH1SLC6A5GSRRNPEPCPB2
SCHEMBL45765 0.98 FOLH1 (0.58) FOLH1SLC6A5GSRRNPEPCPB2
SCHEMBL214641 0.98 FOLH1 (0.58) FOLH1SLC6A5GSRRNPEPCPB2
Acetic Acid SCHEMBL268740 0.97 FOLH1 (0.57) FOLH1SLC6A5GSRRNPEPCPB2
Hydrochloric Acid SCHEMBL1982441 0.95 FOLH1 (0.50) FOLH1SLC6A5GSRCPB2SIRT6
Hydrochloric Acid SCHEMBL1982438 0.95 FOLH1 (0.50) FOLH1SLC6A5GSRCPB2SIRT6
SCHEMBL866580 0.93 FOLH1 (0.51) FOLH1SLC6A5GSRRNPEPCPB2
SCHEMBL867577 0.93 FOLH1 (0.51) FOLH1SLC6A5GSRRNPEPCPB2
SCHEMBL232125 0.93 FOLH1 (0.51) FOLH1SLC6A5GSRRNPEPCPB2
Hydrochloric Acid SCHEMBL15669796 0.86 FOLH1 (0.60) FOLH1SLC6A5GSRRNPEPCPB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3270953-B1 NOVEL TREATMENT METHOD IDOGEN AB (SE) 2021-07-07 EP disclosed
US-20200078453-A1 METHODS OF TREATING A MAMMAL SUFFERING FROM OR SUSCEPTIBLE TO AN IMMUNE REACTION TO DRUG TREATMENT IDOGEN AB (SE) 2020-03-12 US disclosed
US-9907479-B2 Contribution of oxidative stress to AF electrograms NORTHWESTERN UNIVERSITY (US) 2018-03-06 US disclosed
EP-3270953-A1 NOVEL TREATMENT METHOD Idogen AB (SE) 2018-01-24 EP disclosed
US-20170172440-A1 CONTRIBUTION OF OXIDATIVE STRESS TO AF ELECTROGRAMS NORTHWESTERN UNIVERSITY 2017-06-22 US disclosed
US-9615758-B2 Contribution of oxidative stress to AF electrograms NORTHWESTERN UNIVERSITY (US) 2017-04-11 US disclosed
US-20170014499-A1 NOVEL TREATMENT METHOD IDOGEN AB (SE) 2017-01-19 US disclosed
WO-2016146842-A1 NOVEL TREATMENT METHOD IDOGEN AB (SE) 2016-09-22 WO disclosed
US-20140221861-A1 CONTRIBUTION OF OXIDATIVE STRESS TO AF ELECTROGRAMS NORTHWESTERN UNIVERSITY (US) 2014-08-07 US disclosed